Genentech (now a member of the Roche Group), is researching ADCs because this therapeutic option may have the potential to treat cancer and improve patients’ lives. I'm now quoting from a commerical website (www.ResearchADCs.com):
An ADC is a unique combination of a precise and targeted monoclonal antibody, a stable linker, and a potent cytotoxic and is designed to more selectively kill cancer cells while minimizing effects on normal tissue.Will research surrounding ADCs lead to a cure for cancer? I think that most experts will agree that the future of cancer therapy will significantly revolve around targeted biologic agents and small molecules. If you're thinking about a research career, it's probably a good time to be a molecular biologist who also has extensive knowledge about nanotechnology.